Showing results (411-420 of 1,750) with videos related to
Sort By:
Pageof 175
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 22, 2023
A Novel Cell-based Luciferase Reporter Platform for the Development and Characterization of T-Cell Redirecting Therapies and Vaccine DevelopmentJamison Grailer, Zhijie Jey Cheng, Jim Hartnett, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 5, 2021
Encephalitis Associated With Immune Checkpoint Inhibitor Treatment in Patients With MelanomaClara Martínez-Vila, Juan C Laguna, Elia Segui, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 12, 2021
The Prognostic Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Melanoma Patients Receiving ImmunotherapyYayun Li, Yu Meng, Huiyan Sun, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 8, 2023
Development of Engineered CAR T Cells Targeting Tumor-Associated Glycoforms of MUC1 for the Treatment of Intrahepatic CholangiocarcinomaLi Mao, Sheng Su, Jia Li, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 15, 2022
Large Scale Ex Vivo Expansion of γδ T cells Using Artificial Antigen-presenting CellsJustin C Boucher, Bin Yu, Gongbo Li, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 21, 2025
Integrating Bulk RNA-Seq and Spatial Transcriptomics Data to Reveal Distinct Immune Escape Mechanism and Immunotherapy Based on Post-Translational Modification in Head and Neck Squamous Cell CarcinomaKai Li, Chuyi Cai, Qingmei Chen, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 26, 2019
Combination Therapy of Ipilimumab and Nivolumab-associated Toxic Epidermal Necrolysis (TEN) in a Patient With Metastatic Melanoma: A Case Report and Literature ReviewIan T Logan, Saman Zaman, Lama Hussein, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 1, 2021
Management and Outcomes of Hematological Immune-related Adverse Events: Systematic Review and Meta-analysisNathaniel R Wilson, Jonathan R Lockhart, Herney A Garcia-Perdomo, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 17, 2025
Synergistic Effect of Anti-PD-L1 Treatment and CD8+ T-Cell Activating Nanotherapy in Pancreatic Ductal Adenocarcinoma Evaluated via 3D Mathematical ModelingDylan A Goodin, Tina Daunke, Silje Beckinger, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 24, 2025
FGL1 as an Immune Checkpoint in the Immune Microenvironment of Bladder CancerKeyao Hu, Xiaocheng Ma, Lei Luo, et al.Pageof 175